Key Points

  • The KOSPI Composite Index (^KS11) fell approximately 8.77% over the trading week, closing at 6,820.60.
  • A sharp 6.37% decline in the final session exacerbated the week's losses, driven by a broad selloff in major semiconductor and artificial intelligence-linked companies.
  • Market sentiment remains tied to the Bank of Korea's monetary policy, domestic regulatory measures on leveraged ETFs, and shifting global tech valuations.
hero

The KOSPI Composite Index ended the trading week significantly lower, plunging approximately 8.77% over the week before closing at 6,820.60. The benchmark’s sharp late-week weakness, capped by a 6.37% daily drop, reflected intense profit-taking and a broader deterioration in investor sentiment, as markets continued to assess South Korea’s tech sector vulnerabilities alongside evolving global macroeconomic conditions.

The week’s trading reflected severe volatility across South Korean markets, with investors evaluating central bank interest rate expectations, inflation trends, and the outlook for regional economic stability amid an increasingly complex global environment.

South Korean Equities Face Intense Tech-Driven Selloff

Throughout most of the week, South Korean equities experienced aggressive downward pressure, with the KOSPI index failing to sustain upward momentum before retreating sharply during the final session. The late-week decline of 6.37% weighed heavily on overall performance, erasing prior advances and suggesting that investors remained highly cautious about maintaining exposure to domestic large-cap technology companies despite previous rallies.

Technology companies, particularly heavyweight memory chipmakers and artificial intelligence-related businesses, largely drove the index’s underperformance. Investors generally reacted negatively to concerns over fading AI momentum and escalating geopolitical tensions, which triggered widespread selling across the semiconductor sector.

Macro Developments Continue to Drive Sentiment

Investor attention remained focused on several macroeconomic themes, including South Korea’s growth trajectory, monetary policy expectations, and international trade developments. Markets monitored the Bank of Korea’s policy stance aimed at curbing inflationary pressures stemming from rising global energy prices and regional uncertainties.

At the same time, domestic regulatory risks continue to shape investor positioning. In response to extreme market swings, South Korean financial regulators have closely monitored volatility tied to major chipmakers. These regulatory considerations, alongside evolving global supply chain uncertainties, remain important variables for KOSPI-listed companies.

Israeli Investors Monitor Asian Market Diversification

For Israeli investors, South Korea remains an important gateway to broader Asian equity markets and technological innovation. Institutional portfolios often gain indirect exposure to South Korean semiconductor giants, automotive manufacturing, and financial services through global exchange-traded funds and international equity allocations.

However, exposure to the region also carries additional considerations, including currency fluctuations, regulatory developments in Seoul, and shifts in global investor risk appetite. As a result, portfolio managers continue emphasizing diversification while closely monitoring corporate earnings quality and policy announcements that could influence regional valuations.

Outlook: The near-term outlook for the KOSPI Composite Index remains cautious and highly dependent on incoming economic data and policy signals from the Bank of Korea. Stable global commodity prices, improving corporate earnings in the tech sector, and easing geopolitical tensions could provide foundational support for equities. Conversely, renewed inflationary spikes, weaker-than-expected semiconductor demand, or additional regulatory restrictions could increase market volatility. For long-term investors, South Korea continues to offer access to some of Asia’s largest technological innovators, although maintaining a balanced assessment of both opportunities and downside risks remains appropriate as global macroeconomic conditions continue to evolve.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | Tel Aviv Equities Edge Lower as TA-90 and TA-125 Face Broad Selling Pressure
    • orshu
    • 8 Min Read
    • ago 6 hours

    SKN | Tel Aviv Equities Edge Lower as TA-90 and TA-125 Face Broad Selling Pressure SKN | Tel Aviv Equities Edge Lower as TA-90 and TA-125 Face Broad Selling Pressure

    Tel Aviv financial markets are trading slightly lower as investors continue to navigate a cautious environment following recent market volatility.

    • ago 6 hours
    • 8 Min Read

    Tel Aviv financial markets are trading slightly lower as investors continue to navigate a cautious environment following recent market volatility.

    SKN | Global Markets Target United Kingdom Inflation Telemetry and Mega Cap Tech Earnings as Mid Summer Volatility Rises
    • orshu
    • 7 Min Read
    • ago 10 hours

    SKN | Global Markets Target United Kingdom Inflation Telemetry and Mega Cap Tech Earnings as Mid Summer Volatility Rises SKN | Global Markets Target United Kingdom Inflation Telemetry and Mega Cap Tech Earnings as Mid Summer Volatility Rises

    Global capital markets advance into the trading week of July 20, 2026, navigating a high impact intersection of inflation data

    • ago 10 hours
    • 7 Min Read

    Global capital markets advance into the trading week of July 20, 2026, navigating a high impact intersection of inflation data

    SKN | Samsung Biologics’ $1.8 Billion Bid for PolyPeptide Signals a New Push in Global Biopharma Manufacturing
    • omer bar
    • 6 Min Read
    • ago 12 hours

    SKN | Samsung Biologics’ $1.8 Billion Bid for PolyPeptide Signals a New Push in Global Biopharma Manufacturing SKN | Samsung Biologics’ $1.8 Billion Bid for PolyPeptide Signals a New Push in Global Biopharma Manufacturing

    Samsung Biologics is set to launch a $1.8 billion all-cash bid for PolyPeptide, marking one of the biotechnology manufacturing sector's

    • ago 12 hours
    • 6 Min Read

    Samsung Biologics is set to launch a $1.8 billion all-cash bid for PolyPeptide, marking one of the biotechnology manufacturing sector's

    SKN | Asian Markets Mixed on July 20 as India Leads Gains While Japan and China Drive Regional Selloff
    • Ronny Mor
    • 8 Min Read
    • ago 13 hours

    SKN | Asian Markets Mixed on July 20 as India Leads Gains While Japan and China Drive Regional Selloff SKN | Asian Markets Mixed on July 20 as India Leads Gains While Japan and China Drive Regional Selloff

    Asian equity markets traded with mixed performance during Monday morning's session on July 20 as gains in India and Australia

    • ago 13 hours
    • 8 Min Read

    Asian equity markets traded with mixed performance during Monday morning's session on July 20 as gains in India and Australia